ArticleEuropean heart journal2026

Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study.

Albree Tower-Rader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.